HIGHLAND_MEDICAL_AESTHETI - Accounts


Company registration number SC613199 (Scotland)
HIGHLAND MEDICAL AESTHETICS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2022
PAGES FOR FILING WITH REGISTRAR
HIGHLAND MEDICAL AESTHETICS LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 MARCH 2022
31 March 2022
- 1 -
2022
2020
£
£
£
£
Fixed assets
65,089
665
Current assets
81,752
65,797
Creditors: amounts falling due within one year
(55,467)
(39,503)
Net current assets
26,285
26,294
Total assets less current liabilities
91,374
26,959
Creditors: amounts falling due after more than one year
(70,912)
(22,500)
Net assets
20,462
4,459
Capital and reserves
20,462
4,459
Notes to the financial statements
1
Employees

The average number of persons, including directors, employed by the company during the period was as follows:

2022
2020
Number
Number
Employees
2
1
2
Director's transactions

During the period the directors introduced funds to the company totalling £60,527 (2020 - £nil) and withdrew funds of £72,850 (2020 - £2,931).

 

At the period end, one director owed the company £22,276 (2020 - £9,953) which is included in current assets and another director is owed £20,000 (2020 - £nil) from the company, which is included in creditors due within one year.

 

Loans with the directors are repayable on demand and no interest is charged.

 

HIGHLAND MEDICAL AESTHETICS LIMITED
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
31 MARCH 2022
31 March 2022
- 2 -
3
Transition to FRS 105

These financial statements for the period ended 31 March 2022 are the company's first financial statements prepared that comply with FRS 105. The company's date of transition to FRS 105 is 1 December 2019. The company's last financial statements prepared in accordance with FRS 102 section 1A, were for the year ended 30 November 2020.

 

The transition to FRS 105 has resulted in a change to the treatment of deferred tax. In accordance with FRS 102 section 1A, deferred tax was recognised on short term timing differences. In accordance with FRS 105, no deferred tax should be recognised. As such the deferred tax charge for the year ended 30 November 2020 has been removed (£126).

 

The effect of this transition has increased profit after tax for the financial year ended 30 November 2020 from £22,378 to £22,504. Profit and loss reserves as at 30 November 2020 has also increased from £4,332 to £4,458.

Highland Medical Aesthetics Limited is a private company limited by shares incorporated in Scotland. The registered office is 7 Lochandinty Road, Tornagrain, Inverness, United Kingdom, IV2 8AJ.

For the period ended 31 March 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 23 December 2022 and are signed on its behalf by:
Ms E Lowe
Director
Company Registration Number SC613199
2022-03-312020-12-01falseCCH SoftwareCCH Accounts Production 2022.300Ms E LoweDr J ElderMs C LeeSC6131992020-12-012022-03-31SC6131992022-03-31SC6131992020-11-30SC613199core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-31SC613199core:CurrentFinancialInstrumentscore:WithinOneYear2020-11-30SC613199core:Non-currentFinancialInstruments2022-03-31SC613199core:Non-currentFinancialInstruments2020-11-30SC6131992019-12-012020-11-30SC613199bus:Director12020-12-012022-03-31SC613199bus:PrivateLimitedCompanyLtd2020-12-012022-03-31SC613199bus:SmallCompaniesRegimeForAccounts2020-12-012022-03-31SC613199bus:Micro-entities2020-12-012022-03-31SC613199bus:AuditExemptWithAccountantsReport2020-12-012022-03-31SC613199bus:Director22020-12-012022-03-31SC613199bus:Director32020-12-012022-03-31SC613199bus:FullAccounts2020-12-012022-03-31xbrli:purexbrli:sharesiso4217:GBP